Development and Validation of a UHPLC UV Method for the In-Process Control of Bosentan Monohydrate Synthesis

Bosentan monohydrate (4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl) pyrimidin-4-yl]benzene-1-sulfonamide monohydrate) is a dual endothelin receptor antagonist (ERA) applied in the treatment of pulmonary arterial hypertension. To achieve effective process control of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Jatczak, Marta, Sidoryk, Katarzyna, Kossykowska, Magdalena, Łuniewski, Wojciech, Zagrodzka, Joanna, Lipiec-Abramska, Elżbieta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995228/
https://www.ncbi.nlm.nih.gov/pubmed/27616782
http://dx.doi.org/10.1007/s10337-016-3124-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995228/
https://www.ncbi.nlm.nih.gov/pubmed/27616782
http://dx.doi.org/10.1007/s10337-016-3124-y

Ejemplares similares